SEC Form 4 · accession 0001209191-17-052145
ROCKWELL MEDICAL, INC. · RMTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John G Cooper
Director
Period of report
Sep 5, 2017
Accepted (ET)
Sep 8, 2017 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001041024
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $6.45 | Sep 5, 2017 | A | 23,000 | A | — | Sep 5, 2027 | Common Stock | 23,000 | 23,000 | D |
Explanation of responses
- F1This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, (c) the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic, or (d) immediately prior to a change in control. This grant can only be settled in cash.